Caregiver and health worker views towards the use of BioFire test
Research type
Research Study
Full title
Caregiver and clinician perceptions and influences regarding acceptability, feasibility and adoption of a point of care test: BioFire Film Array Respiratory Panel 2.1 plus (RP2.1plus) when managing respiratory presentations.
IRAS ID
339277
Contact name
Maggie Nyirenda - Nyang'wa
Contact email
Sponsor organisation
Lewisham and Greenwich NHS Trust
Duration of Study in the UK
0 years, 2 months, 30 days
Research summary
Many children come to the paediatric emergency department each day with symptoms of cough, sore throat and fever. Most of these presentations are due to viral illnesses are self-limiting and do not require antibiotics; however, some will that are caused by bacteria will. Current ways to work out what the underlying cause is include: waiting for a PCR (Polymerase chain reaction) result that can take up to 2 days to return, bloods, clinical judgement or a combination of these measures. It is important to know which children require treatment with antibiotics to reduce harm in case they become very sick with a bacterial infection. Equally not prescribing antibiotics is important to a viral illness to reduce the chance of developing antibiotic resistance.
Advances have been made in Point of Care Testing (POCT) kits that can be used in the hospital to speed-up the diagnosis of these presentations. We wish to explored several aspects based on the principles of implementation science as to whether the use of a POCT, specifically the BioFire Film Array Respiratory Panel 2.1 plus (RP2.1plus) is acceptable, feasible and and easy to use and adopt by caregivers and health care workers respectively in a busy District General Hospital (DGH) treating children.REC name
North West - Greater Manchester East Research Ethics Committee
REC reference
24/NW/0393
Date of REC Opinion
17 Feb 2025
REC opinion
Further Information Favourable Opinion